CompletedNot applicableNCT02975895
Outcome of Different IOLs in Patients With and Without Uveitis
Studying Posterior uveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vastra Gotaland Region
- Principal Investigator
- Madeleine Zetterberg, MD, PhDVästra Götalands regionen, Sahlgrenska University Hospital, Department of Ophthalmology
- Intervention
- Hydrophobic IOL: Vivinex (HOYA)(device)
- Enrollment
- 56 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2022
Study locations (1)
- Vastra Gotaland Region, Sahlgrenska University Hospital, Department of Ophthalmology, Mölndal, Sweden
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02975895 on ClinicalTrials.gov